10-Q quarterly report · filed Oct 29, 2026

Pediatrix Medical Group, Inc. (MD) Q3 2026 10-Q Quarterly Report

Short answer

Pediatrix Medical Group, Inc. (MD) filed its Q3 2026 10-Q quarterly report on Oct 29, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $501M (up 1.7% year over year) with net income of $47M.

Q3 2026 key financials · XBRL

Revenue
$501M
+1.7% YoY · +2.8% QoQ
Net income
$47M
−34.5% YoY · +17.9% QoQ
Operating margin
13.0%
EPS (diluted)
$0.58
−31.0% YoY · +18.4% QoQ

Source: XBRL data from the Pediatrix Medical Group, Inc. (MD) Q3 2026 10-Q on SEC EDGAR. USD.

Pediatrix Medical Group, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $501.4M, up 1.7% YoY from $492.9M, driven by acquisitions and same-unit growth
  • Operating margin 13.0% vs 13.8% YoY; net income $47.0M vs $71.7M
  • Maternal-fetal medicine volumes increased; newborn nursery volumes declined
  • Cash $311.9M vs $375.2M at December 31, 2025; operating cash flow $114.5M vs $160.1M
  • Stock repurchases $147.2M; Medicaid reforms, NSA changes and 2027 Medicare fee reduction of 1.19% as headwinds

Risk Factors

  • No material changes to risk factors disclosed in the 2025 Form 10-K
  • Carried-forward regulatory risk, healthcare laws and regulations could affect operations
  • Carried-forward operational risk, physician recruitment and retention could constrain services
  • Carried-forward financial risk, reimbursement pressure could reduce revenue and margins
  • Share-repurchase risk, $21.5 million remaining under the August 2025 program subject to market conditions

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Pediatrix Medical Group, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.